GEN İlaç ve Sağlık Ürünleri A.Ş.

Quick facts

Phase 2 pipeline

• Clobetasol 17-propionate · Dermatology
  Glucocorticoid receptor agonist
• GN-037

Phase 1 pipeline

• Multiple ascending doses SUL-238
• Single ascending doses SUL-238
• Single dose SUL-238

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• GEN İlaç ve Sağlık Ürünleri A.Ş. portfolio CI brief
• GEN İlaç ve Sağlık Ürünleri A.Ş. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies